Dorothy Wiley, M.P.H., Ph.D.

Comparte esta página
Bio Details: 

Dr. Wiley is a tenured Professor and investigator in the UCLA School of Nursing. Her research and scientific leadership centers on epidemiology, and prevention and outcomes associated with human papillomavirus (HPV) and human immunodeficiency virus (HIV) infections. She is a translational scientist whose research interests span biological science and human illness using epidemiological methods to better understand how HPV and HIV, together and apart, influence morbidity and mortality in human populations. Her laboratory research centers on biological factors that influence risk for persistent HPV infection. She leads a clinical-translational investigation that is developing improved anal cancer screening methods for high-risk populations. Her collaboration with the Multicenter AIDS Cohort Study (MACS) Group dates to 1992. From this work data-based research related to HPV has been published in peer-reviewed journals. Data for MACS men contributed to studies about HPV-related risk for genital wart recurrence, cancer risk, condom use, and anal HPV16 infection and cytosine methylation are collaborations with the MACS Group. Additionally, earlier work included work relating receptive anal intercourse to periods of rapid CD4+ cell loss among HIV infected men in the pre-HAART era.

Dr. Wiley chaired the School of Nursing and University-wide governance committees (e.g., UCLA Undergraduate Council, Committee for Undergraduate Admissions and Relations with Schools) and is actively involved in graduate and undergraduate education. She participated in system-wide governance for the University of California Academic Senate (e.g., Board of Admissions and Relations with Schools). I was a past member and co-chair for 1996, 1997, and 2000 CDC, National Center for HIV, STD and TB Prevention, Division of Sexually Transmitted Diseases, STD Treatment Guidelines – HPV/External Genital Warts Treatment, She evaluated evidence from clinical trials, crafted, and disseminated treatment guidelines for genital warts and a past member of the National Cervical Cancer and HPV Advisory Panel for the American Social Health Association and as a member delegate to the American Society for Colposcopy and Cervical Pathology Consensus Conference on Cytological Abnormalities and Cervical Cancer Precursors. She is a member of the UCLA Clinical and Translational Science Institute and a co-leader for the Pilot and Collaborative Translational and Clinical Studies Program.


  • Ph.D., University of California, Los Angeles, CA, 1995
  • Graduate study in Nursing Primary Care, University of California, Los Angeles, CA, 1985-89
  • M.P.H., San Diego State University, San Diego, CA, 1983
  • B.A.&S., San Diego State University, San Diego, CA, 1978